Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

被引:407
作者
Wald, A
Zeh, J
Selke, S
Warren, T
Ryncarz, AJ
Ashley, R
Krieger, JN
Corey, L
机构
[1] Univ Washington, Virol Res Clin, Dept Med, Seattle, WA 98122 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98122 USA
[3] Univ Washington, Dept Stat, Seattle, WA 98122 USA
[4] Univ Washington, Dept Lab Med, Seattle, WA 98122 USA
[5] Univ Washington, Dept Urol, Seattle, WA 98122 USA
[6] Westover Hts Clin, Portland, OR USA
[7] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA
关键词
D O I
10.1056/NEJM200003233421203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Most persons who have serologic evidence of infection with herpes simplex virus (HSV) type 2 (HSV-2) are asymptomatic. Historically, it has been assumed that these persons have less frequent viral reactivation than those with symptomatic infection. Methods: We conducted a prospective study to investigate genital shedding of HSV among 53 subjects who had antibodies to HSV-2 but who reported having no history of genital herpes, and we compared their patterns of viral shedding with those in a similar cohort of 90 subjects with symptomatic HSV-2 infection. Genital secretions of the subjects in both groups were sampled daily and cultured for HSV for a median of 94 days. Results: HSV was isolated from the genital mucosa in 38 of the 53 HSV-2-seropositive subjects (72 percent) who reported no history of genital herpes, and HSV DNA was detected by the polymerase-chain-reaction assay in cultures prepared from genital mucosal swabs in 6 additional subjects. The rate of subclinical shedding of HSV in the subjects with no reported history of genital herpes was similar to that in the subjects with such a history (3.0 percent vs. 2.7 percent). Of the 53 subjects who had no reported history of genital herpes, 33 (62 percent) subsequently reported having typical herpetic lesions; the duration of their recurrences in these subjects was shorter (median, three days vs. five days; P<0.001) and the frequency lower (median, 3.0 per year vs. 8.2 per year; P<0.001) than in the 90 subjects with previously diagnosed symptomatic infection. Only 1 of these 53 subjects had no clinical or virologic evidence of HSV infection. Conclusions: Seropositivity for HSV-2 is associated with viral shedding in the genital tract, even in subjects with no reported history of genital herpes. (N Engl J Med 2000;342:844-50.) (C)2000, Massachusetts Medical Society.
引用
收藏
页码:844 / 850
页数:7
相关论文
共 39 条
[1]  
Ashley R, 1998, SEX TRANSM INFECT, V74, P228
[2]   INABILITY OF ENZYME IMMUNOASSAYS TO DISCRIMINATE BETWEEN INFECTIONS WITH HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 [J].
ASHLEY, R ;
CENT, A ;
MAGGS, V ;
NAHMIAS, A ;
COREY, L .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (07) :520-526
[3]   COMPARISON OF WESTERN BLOT (IMMUNOBLOT) AND GLYCOPROTEIN-G-SPECIFIC IMMUNODOT ENZYME ASSAY FOR DETECTING ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 IN HUMAN-SERA [J].
ASHLEY, RL ;
MILITONI, J ;
LEE, F ;
NAHMIAS, A ;
COREY, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (04) :662-667
[4]   UNDERESTIMATION OF HSV-2 SEROPREVALENCE IN A HIGH-RISK POPULATION BY MICRONEUTRALIZATION ASSAY [J].
ASHLEY, RL ;
DALESSIO, J ;
DRAGAVON, J ;
KOUTSKY, LA ;
LEE, FK ;
NAHMIAS, AJ ;
STEVENS, CE ;
HOLMES, KK ;
COREY, L .
SEXUALLY TRANSMITTED DISEASES, 1993, 20 (04) :230-235
[5]   Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies [J].
Ashley, RL ;
Wu, LX ;
Pickering, JW ;
Tu, MC ;
Schnorenberg, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (01) :294-295
[6]   RECURRENCE RATES IN GENITAL HERPES AFTER SYMPTOMATIC FIRST-EPISODE INFECTION [J].
BENEDETTI, J ;
COREY, L ;
ASHLEY, R .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (11) :847-854
[7]   Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time [J].
Benedetti, JK ;
Zeh, J ;
Corey, L .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :14-+
[8]   Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection - Two randomized controlled trials [J].
Corey, L ;
Langenberg, AGM ;
Ashley, R ;
Sekulovich, RE ;
Izu, AE ;
Douglas, JM ;
Handsfield, HH ;
Warren, T ;
Marr, L ;
Tyring, S ;
DiCarlo, R ;
Adimora, AA ;
Leone, P ;
Dekker, CL ;
Burke, RL ;
Leong, WP ;
Straus, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (04) :331-340
[9]   ANTIBODY TO HERPES-SIMPLEX VIRUS TYPE-2 AS SEROLOGICAL MARKER OF SEXUAL LIFE-STYLE IN POPULATIONS [J].
COWAN, FM ;
JOHNSON, AM ;
ASHLEY, R ;
COREY, L ;
MINDEL, A .
BRITISH MEDICAL JOURNAL, 1994, 309 (6965) :1325-1329
[10]   Herpes simplex virus type 2 in the United States, 1976 TO 1994 [J].
Fleming, DT ;
McQuillan, GM ;
Johnson, RE ;
Nahmias, AJ ;
Aral, SO ;
Lee, FK ;
StLouis, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (16) :1105-1111